Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) were down 10.7% during trading on Tuesday . The company traded as low as C$0.13 and last traded at C$0.13. Approximately 116,378 shares changed hands during trading, a decline of 13% from the average daily volume of 134,179 shares. The stock had previously closed at C$0.14.
VentriPoint Diagnostics Stock Down 3.7%
The company has a quick ratio of 6.67, a current ratio of 0.08 and a debt-to-equity ratio of -63.20. The company has a market capitalization of C$24.40 million, a PE ratio of -6.50 and a beta of -0.92. The business’s 50 day simple moving average is C$0.12 and its 200 day simple moving average is C$0.12.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
